Immunohistochemical analysis of phosphorylated STAT6 protein expression in lymphomas
Case no. . | Diagnosis . | Sex and age, y . | Site . | P-STAT6 staining . |
|---|---|---|---|---|
| 1 | PMBL | F, 33 | Med | ++ |
| 2 | PMBL | F, 57 | Med | − |
| 3 | PMBL | F, 40 | Med | ++ |
| 4 | PMBL | M, 62 | Med | − |
| 5 | PMBL | F, 54 | Med | ++ |
| 6 | PMBL | M, 27 | Med | + |
| 7 | PMBL | M, 66 | Med | + |
| 8 | PMBL | F, 23 | Med | + |
| 9 | PMBL | F, 37 | Med | − |
| 10 | PMBL | M, 23 | Cervical LN* | ++ |
| 11 | PMBL | F, 50 | Med | + |
| 12 | DLBCL | F, 33 | Axillary LN | − |
| 13 | DLBCL | M, 78 | Axillary LN | − |
| 14 | DLBCL | F, 49 | Inguinal LN | − |
| 15 | DLBCL | M, 54 | Cervical LN | − |
| 16 | DLBCL | M, 60 | Cervical LN | + |
| 17 | DLBCL | M, 55 | Cervical LN | − |
| 18 | DLBCL | M, 70 | Inguinal LN | − |
| 19 | DLBCL | F, 68 | Cervical LN | − |
| 20 | DLBCL | M, 61 | Inguinal LN | − |
| 21 | DLBCL | F, 68 | Axillary LN | − |
| 22 | cHL, NS | F, 20 | Cervical LN | +++ |
| 23 | cHL, NS | F, 22 | Cervical LN | +++ |
| 24 | cHL, NS | F, 26 | Cervical LN | +++ |
| 25 | cHL, NS | F, 40 | Cervical LN | +++ |
| 26 | cHL, NS | F, 24 | Cervical LN | − |
Case no. . | Diagnosis . | Sex and age, y . | Site . | P-STAT6 staining . |
|---|---|---|---|---|
| 1 | PMBL | F, 33 | Med | ++ |
| 2 | PMBL | F, 57 | Med | − |
| 3 | PMBL | F, 40 | Med | ++ |
| 4 | PMBL | M, 62 | Med | − |
| 5 | PMBL | F, 54 | Med | ++ |
| 6 | PMBL | M, 27 | Med | + |
| 7 | PMBL | M, 66 | Med | + |
| 8 | PMBL | F, 23 | Med | + |
| 9 | PMBL | F, 37 | Med | − |
| 10 | PMBL | M, 23 | Cervical LN* | ++ |
| 11 | PMBL | F, 50 | Med | + |
| 12 | DLBCL | F, 33 | Axillary LN | − |
| 13 | DLBCL | M, 78 | Axillary LN | − |
| 14 | DLBCL | F, 49 | Inguinal LN | − |
| 15 | DLBCL | M, 54 | Cervical LN | − |
| 16 | DLBCL | M, 60 | Cervical LN | + |
| 17 | DLBCL | M, 55 | Cervical LN | − |
| 18 | DLBCL | M, 70 | Inguinal LN | − |
| 19 | DLBCL | F, 68 | Cervical LN | − |
| 20 | DLBCL | M, 61 | Inguinal LN | − |
| 21 | DLBCL | F, 68 | Axillary LN | − |
| 22 | cHL, NS | F, 20 | Cervical LN | +++ |
| 23 | cHL, NS | F, 22 | Cervical LN | +++ |
| 24 | cHL, NS | F, 26 | Cervical LN | +++ |
| 25 | cHL, NS | F, 40 | Cervical LN | +++ |
| 26 | cHL, NS | F, 24 | Cervical LN | − |
PMBL indicates primary mediastinal B-cell lymphoma; F, female; med, mediastinum; M, male; LN, lymph node; DLBCL, nonmediastinal diffuse large B-cell lymphoma; and cHL, NS, classical Hodgkin lymphoma, nodular sclerosis type. ++ indicates 25% to 50% positive tumoral cells; +, 10% to 20% positive tumoral cells; and −, less than 10% positive tumoral cells.
Patient with bulky mediastinal mass.